Updated: March 2026.

Kevin Martínez-Folgar, MD, PhD

Physician-scientist with research in cancer epidemiology, molecular approaches, and data science, focused on understanding why cancer burdens are distributed unequally across populations. Work integrates global cancer surveillance, exposomic and biomarker frameworks, and AI-enabled analytic workflows to generate evidence for policy and clinical practice.

Contact: GitHub · ORCID · Google Scholar


Education & Training

Scientist, 2026–Present Cancer Surveillance Branch, International Agency for Research on Cancer (IARC), WHO — Lyon, France

Postdoctoral Research Fellow, 2025–2026 Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute (NCI), NIH

Impact Scholar (Postdoctoral Research Fellow), 2023–2025 Center for Global Health Equity, University of Michigan

PhD in Epidemiology, 2019–2023 Dornsife School of Public Health, Drexel University

MD (Physician), 2010–2016 University of San Carlos of Guatemala


Professional Experience

Scientist, 2026–Present Cancer Surveillance Branch, International Agency for Research on Cancer (IARC), WHO — Lyon, France Global cancer epidemiology, pediatric cancer surveillance, and molecular epidemiology at a global scale.

Postdoctoral Research Fellow, 2025–2026 Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI/NIH Research on social and environmental determinants of cancer risk and disparities across diverse populations.

Impact Scholar (Postdoctoral Research Fellow), 2023–2025 Center for Global Health Equity, University of Michigan Research on cancer and chronic disease disparities, health equity in Latin American and U.S. contexts.

Graduate Research Fellow, 2019–2023 Urban Health Collaborative, Drexel University SALURBAL study — multilevel analyses of urban environments and health outcomes across Latin American cities.

Researcher, 2017–2019 INCAP Research Center for Prevention of Chronic Diseases (CIIPEC), Guatemala City Stakeholder engagement, chronic disease prevention, hypertension control programs.


Core Methods & Skills

  • Cancer epidemiology and global cancer surveillance
  • Cancer disparities and cancer outcomes research
  • Infection-related and gastrointestinal malignancies
  • Molecular epidemiology and biomarker approaches
  • Proteomics
  • Social epidemiology and urban health
  • Multilevel and longitudinal analysis
  • Mortality and life expectancy estimation
  • Geospatial analysis (GIS)
  • Causal inference and mediation analysis
  • R and Python (reproducible analytic workflows)
  • AI-assisted data capture and analysis
  • Data visualization and science communication

Selected Publications

  • Martinez-Folgar K, Alburez-Gutierrez D, Paniagua-Avila A, Ramirez-Zea M, Bilal U. Excess mortality during the COVID-19 pandemic in Guatemala. American Journal of Public Health (2021). DOI: 10.2105/AJPH.2021.306452

  • Bilal U, Alazraqui M, Caiaffa W, Lopez-Olmedo N, Martinez-Folgar K, et al. Inequalities in life expectancy in six large Latin American cities from the SALURBAL study. The Lancet Planetary Health (2019). DOI: 10.1016/S2542-5196(19)30235-9

  • Mullachery P, Rodriguez D, Miranda J, Lopez-Olmedo N, Martinez-Folgar K, et al. Mortality amenable to healthcare in Latin American cities. International Journal of Epidemiology (2022). DOI: 10.1093/ije/dyab137

  • Alfaro T, Martinez-Folgar K, Vives A, Bilal U. Excess mortality during the COVID-19 pandemic in cities of Chile. Journal of Urban Health (2022). DOI: 10.1007/s11524-022-00658-y

  • Lima E, Vilela E, Peralta A, …, Martinez-Folgar K, et al. Investigating regional excess mortality during 2020 COVID-19 pandemic in selected Latin American countries. Genus (2021). DOI: 10.1186/s41118-021-00139-1

For a complete and up-to-date list, see Google Scholar or the publications page.


Selected Grants & Funding

Principal Investigator (2024): Race and Ethnic Disparities in Health Outcomes in Guatemala ($5,000)

Principal Investigator (2023): Geographic Capital and Health Disparities in Chronic Diseases ($7,000)